Table 1.
Population characteristics
| Parameters | N° of newborns | % | Parameters | N° of newborns | % |
|---|---|---|---|---|---|
| GA (weeks) |
|
|
RDS |
384 |
99.7% |
| 22–23 - 24 |
92 |
22.6% |
PDA |
251 |
65.0% |
| 25 |
102 |
24.2% |
IVH |
167 |
43.5% |
| 26 |
134 |
31.8% |
LPV |
99 |
26.7% |
| ≥ 27 |
90 |
21.4% |
Fungal Sepsis |
46 |
11.4% |
| |
|
|
Bacterial Sepsis |
178 |
44.2% |
| BW (g) |
|
|
BPD |
208 |
54.9% |
| 300–450 |
9 |
2.1% |
Blood transfusions |
357 |
89.9% |
| 451–600 |
70 |
16.6% |
EPO therapy |
210 |
55.6% |
| 601–750 |
167 |
39.7% |
Mechanical ventilation ( > 7 days) |
258 |
69.2% |
| > 750 |
175 |
41.6% |
NPT ( > 7 days) |
303 |
80.6% |
| Male |
182 |
45.5% |
ROP |
265 |
62.9% |
| Inborn |
358 |
88.0% |
P - ROP |
102 |
24.2% |
| APGAR score 5th minute ≤ 7 |
176 |
47.7% |
Preplus disease |
55 |
13.1% |
| PROM |
122 |
31.9% |
Plus disease |
79 |
18.8% |
| Chorioamnionitis |
93 |
27.8% |
Laser treatment |
89 |
21.1% |
| Antenatal steroids | 331 | 84.0% | Adverse outcome | 14 | 3.3% |